Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€3.09

€3.09

3.840%
0.122
3.840%
-
 
12.12.25 / Tradegate WKN: A2QKXS / Name: Abcellera Biologics Inc. / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Abcellera Biologics Inc. Stock

Abcellera Biologics Inc. dominated the market today, gaining €0.12 (3.840%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Abcellera Biologics Inc. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Abcellera Biologics Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

News

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025
AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025


AbCellera (Nasdaq: ABCL) will announce its second quarter 2025 financial results on Thursday, August 7, 2025, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time)